A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
Clinical trial NCT02954406 · TERMINATED
Trial details
- NCT number
- NCT02954406
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-05
- Primary completion
- 2020-07-27
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.